BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8720930)

  • 1. [Molecular cancer epidemiology--the present status and future possibilities].
    Sakai T
    Nihon Eiseigaku Zasshi; 1996 Feb; 50(6):1036-46. PubMed ID: 8720930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A silencer element in the retinoblastoma tumor-suppressor gene.
    Ohtani-Fujita N; Fujita T; Takahashi R; Robbins PD; Dryja TP; Sakai T
    Oncogene; 1994 Jun; 9(6):1703-11. PubMed ID: 8183566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The retinoblastoma binding factor 1 (RBF-1) site in RB gene promoter binds preferentially E4TF1, a member of the Ets transcription factors family.
    Savoysky E; Mizuno T; Sowa Y; Watanabe H; Sawada J; Nomura H; Ohsugi Y; Handa H; Sakai T
    Oncogene; 1994 Jul; 9(7):1839-46. PubMed ID: 8208529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoblastoma binding factor 1 site in the core promoter region of the human RB gene is activated by hGABP/E4TF1.
    Sowa Y; Shiio Y; Fujita T; Matsumoto T; Okuyama Y; Kato D; Inoue J; Sawada J; Goto M; Watanabe H; Handa H; Sakai T
    Cancer Res; 1997 Aug; 57(15):3145-8. PubMed ID: 9242441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gene-regulating chemoprevention against cancer--as a model for "molecular-targeting prevention" of cancer].
    Sowa Y; Sakai T
    Nihon Eiseigaku Zasshi; 2003 May; 58(2):267-74. PubMed ID: 12806965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer risks from germ line tumor suppressor gene mutations.
    Frebourg T; Malkin D; Friend S
    Princess Takamatsu Symp; 1991; 22():61-70. PubMed ID: 1844252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tumor suppressor genes and their role in abnormal production of leukocytes (leukemogenesis)].
    Furukawa Y
    Rinsho Ketsueki; 1993 May; 34(5):572-7. PubMed ID: 8315827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a p53 binding site in the human retinoblastoma susceptibility gene promoter.
    Osifchin NE; Jiang D; Ohtani-Fujita N; Fujita T; Carroza M; Kim SJ; Sakai T; Robbins PD
    J Biol Chem; 1994 Mar; 269(9):6383-9. PubMed ID: 8119988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene.
    Ohtani-Fujita N; Fujita T; Aoike A; Osifchin NE; Robbins PD; Sakai T
    Oncogene; 1993 Apr; 8(4):1063-7. PubMed ID: 8455933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein.
    Frebourg T; Kassel J; Lam KT; Gryka MA; Barbier N; Andersen TI; Børresen AL; Friend SH
    Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6413-7. PubMed ID: 1631137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter activation and following induction of the p21/WAF1 gene by flavone is involved in G1 phase arrest in A549 lung adenocarcinoma cells.
    Bai F; Matsui T; Ohtani-Fujita N; Matsukawa Y; Ding Y; Sakai T
    FEBS Lett; 1998 Oct; 437(1-2):61-4. PubMed ID: 9804172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of tumor suppressors on cell cycle-regulatory genes: RB suppresses p34cdc2 expression and normal p53 suppresses cyclin A expression.
    Yamamoto M; Yoshida M; Ono K; Fujita T; Ohtani-Fujita N; Sakai T; Nikaido T
    Exp Cell Res; 1994 Jan; 210(1):94-101. PubMed ID: 8270002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell cycle-dependent modulation of promoter activities of RB and WAF1/Cip1 genes.
    Matsumoto T; Ohtani-Fujita N; Sowa Y; Bai F; Nikaido T; Tamaki T; Sakai T
    Jpn J Cancer Res; 1998 Jun; 89(6):626-33. PubMed ID: 9703360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human retinoblastoma susceptibility gene promoter is positively autoregulated by its own product.
    Park K; Choe J; Osifchin NE; Templeton DJ; Robbins PD; Kim SJ
    J Biol Chem; 1994 Feb; 269(8):6083-8. PubMed ID: 8119953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor suppressor genes: a new era for molecular genetic studies of cancer.
    Lee EY
    Breast Cancer Res Treat; 1991 Sep; 19(1):3-13. PubMed ID: 1756264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
    Li JM; Hu PP; Shen X; Yu Y; Wang XF
    Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
    Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
    Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The structure, function and mutation of Rb gene promoter in normal individuals and retinoblastoma patients].
    Huang Q; Wang J; Tao Y
    Zhonghua Zhong Liu Za Zhi; 1998 May; 20(3):165-7. PubMed ID: 10920996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in expression of E2F-1 and E2F-responsive genes by RB, p53 and p21(Sdi1/WAF1/Cip1) expression.
    Ookawa K; Tsuchida S; Kohno T; Yokota J
    FEBS Lett; 2001 Jun; 500(1-2):25-30. PubMed ID: 11434920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tumor suppressor genes: mutations in RB and p53 genes are significant carcinogenic factors].
    Wiman KG
    Lakartidningen; 1992 Sep; 89(39):3169-74. PubMed ID: 1405928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.